On (b)(6) 2013, a 19mm sjm trifecta valve was implanted due to congenital aortic bicuspid valve.Additionally, the patient had mitral regurgitation and mitral valve annuloplasty and the ascending aortic replacement procedures done at the same time.In (b)(6) 2019, the patient developed anemia following a transverse colectomy.In (b)(6) 2019, aortic stenosis occurred with peak gradient as 64mmhg; the patient was asymptomatic and was monitored.However, the peak gradient increased to 77mmhg with a mean pg of 48mmhg.Therefore, on (b)(6) 2020, the patient underwent re-do aortic valve replacement (avr) and the trifecta valve was explanted due to hemolytic anemia.Upon explant, pannus formation on the lcc and ncc inflow sides and sclerosis due to calcification of the leaflets were confirmed.A new 17mm sjm regent heart valve was successfully implanted.The patient was reported to be in stable condition.
|
Explant was reported due to hemolytic anemia.Also reported was stenosis, pannus and calcifications.The investigation found that all three leaflets contained calcifications.There was circumferential fibrous pannus ingrowth on the inflow surface which extended onto the base of all three leaflets.On the outflow surface, pannus extended onto leaflet 3.All three leaflets had fibrous thickening.Leaflet 3 contained a tear or excised tissue at the free edge.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The calcifications and pannus noted could have contributed to the reported stenosis.
|